Comparison of binding by concentrated peritoneal dialysate and serum

P. F. Gulyassy, T. A. Depner, Gregory C. Shearer

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Major advances in dialysis therapy have occurred over the last decade, yet various abnormalities persist in end-stage renal disease (ESRD) patients. The etiology of these residual defects remains largely unknown. We are currently testing the hypothesis that some of these abnormalities are due to retention of small molecular weight, protein bound toxins, which are poorly dialyzable. We sought an alternative to blood as a source of bound toxins. Spent peritoneal dialysate (PD) was tested as a source. With use of a series of filtration devices, PD albumin content was increased about 35-fold. Evidence of bound ligands was shown by two methods. Salicylate binding by patients' sera and concentrated PD (n=8) were markedly reduced, unbound salicylate being 14.9 ± 5.1% (SD) and 15.8 ± 4.9% at albumin concentrations of 3.30 ± 1.04 and 3.23 ± 0.84 g/dl. Serum from eight normal subjects, diluted to 2.95 g/dl albumin, had 7.4 ± 1.1% unbound salicylate. HPLC analysis of deproteinized concentrated dialysate was compared to ultrafiltrates of the same fluid. Numerous bound peaks were seen, particularly in the late eluting peaks. Spent PD is a rich source of protein bound ligands for further study.

Original languageEnglish (US)
JournalASAIO Journal
Volume39
Issue number3
DOIs
StatePublished - Jan 1 1993

Fingerprint

Dialysis Solutions
Ligands
Salicylates
Proteins
Dialysis
Albumins
Serum
Blood
Molecular weight
Defects
Fluids
Testing
Chronic Kidney Failure
Molecular Weight
High Pressure Liquid Chromatography
Equipment and Supplies

All Science Journal Classification (ASJC) codes

  • Biophysics
  • Bioengineering
  • Biomaterials
  • Biomedical Engineering

Cite this

@article{93bfd82a4727481dbe5cc341170df302,
title = "Comparison of binding by concentrated peritoneal dialysate and serum",
abstract = "Major advances in dialysis therapy have occurred over the last decade, yet various abnormalities persist in end-stage renal disease (ESRD) patients. The etiology of these residual defects remains largely unknown. We are currently testing the hypothesis that some of these abnormalities are due to retention of small molecular weight, protein bound toxins, which are poorly dialyzable. We sought an alternative to blood as a source of bound toxins. Spent peritoneal dialysate (PD) was tested as a source. With use of a series of filtration devices, PD albumin content was increased about 35-fold. Evidence of bound ligands was shown by two methods. Salicylate binding by patients' sera and concentrated PD (n=8) were markedly reduced, unbound salicylate being 14.9 ± 5.1{\%} (SD) and 15.8 ± 4.9{\%} at albumin concentrations of 3.30 ± 1.04 and 3.23 ± 0.84 g/dl. Serum from eight normal subjects, diluted to 2.95 g/dl albumin, had 7.4 ± 1.1{\%} unbound salicylate. HPLC analysis of deproteinized concentrated dialysate was compared to ultrafiltrates of the same fluid. Numerous bound peaks were seen, particularly in the late eluting peaks. Spent PD is a rich source of protein bound ligands for further study.",
author = "Gulyassy, {P. F.} and Depner, {T. A.} and Shearer, {Gregory C.}",
year = "1993",
month = "1",
day = "1",
doi = "10.1097/00002480-199307000-00085",
language = "English (US)",
volume = "39",
journal = "ASAIO Journal",
issn = "1058-2916",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

Comparison of binding by concentrated peritoneal dialysate and serum. / Gulyassy, P. F.; Depner, T. A.; Shearer, Gregory C.

In: ASAIO Journal, Vol. 39, No. 3, 01.01.1993.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Comparison of binding by concentrated peritoneal dialysate and serum

AU - Gulyassy, P. F.

AU - Depner, T. A.

AU - Shearer, Gregory C.

PY - 1993/1/1

Y1 - 1993/1/1

N2 - Major advances in dialysis therapy have occurred over the last decade, yet various abnormalities persist in end-stage renal disease (ESRD) patients. The etiology of these residual defects remains largely unknown. We are currently testing the hypothesis that some of these abnormalities are due to retention of small molecular weight, protein bound toxins, which are poorly dialyzable. We sought an alternative to blood as a source of bound toxins. Spent peritoneal dialysate (PD) was tested as a source. With use of a series of filtration devices, PD albumin content was increased about 35-fold. Evidence of bound ligands was shown by two methods. Salicylate binding by patients' sera and concentrated PD (n=8) were markedly reduced, unbound salicylate being 14.9 ± 5.1% (SD) and 15.8 ± 4.9% at albumin concentrations of 3.30 ± 1.04 and 3.23 ± 0.84 g/dl. Serum from eight normal subjects, diluted to 2.95 g/dl albumin, had 7.4 ± 1.1% unbound salicylate. HPLC analysis of deproteinized concentrated dialysate was compared to ultrafiltrates of the same fluid. Numerous bound peaks were seen, particularly in the late eluting peaks. Spent PD is a rich source of protein bound ligands for further study.

AB - Major advances in dialysis therapy have occurred over the last decade, yet various abnormalities persist in end-stage renal disease (ESRD) patients. The etiology of these residual defects remains largely unknown. We are currently testing the hypothesis that some of these abnormalities are due to retention of small molecular weight, protein bound toxins, which are poorly dialyzable. We sought an alternative to blood as a source of bound toxins. Spent peritoneal dialysate (PD) was tested as a source. With use of a series of filtration devices, PD albumin content was increased about 35-fold. Evidence of bound ligands was shown by two methods. Salicylate binding by patients' sera and concentrated PD (n=8) were markedly reduced, unbound salicylate being 14.9 ± 5.1% (SD) and 15.8 ± 4.9% at albumin concentrations of 3.30 ± 1.04 and 3.23 ± 0.84 g/dl. Serum from eight normal subjects, diluted to 2.95 g/dl albumin, had 7.4 ± 1.1% unbound salicylate. HPLC analysis of deproteinized concentrated dialysate was compared to ultrafiltrates of the same fluid. Numerous bound peaks were seen, particularly in the late eluting peaks. Spent PD is a rich source of protein bound ligands for further study.

UR - http://www.scopus.com/inward/record.url?scp=0027521955&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027521955&partnerID=8YFLogxK

U2 - 10.1097/00002480-199307000-00085

DO - 10.1097/00002480-199307000-00085

M3 - Article

C2 - 8268601

AN - SCOPUS:0027521955

VL - 39

JO - ASAIO Journal

JF - ASAIO Journal

SN - 1058-2916

IS - 3

ER -